Key Details
Last Dividend
$15.10Annual ROE
-6.30%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 02, 2024Recent annual earnings:
Mar 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
May 09, 2024Next split:
N/ARecent split:
Sept 06, 2019Analyst ratings
Recent major analysts updates
22 Oct '18 Baird
Neutral26 June '18 Baird
Neutral25 June '18 JP Morgan
Underweight07 Oct '16 JP Morgan
Neutral19 Aug '16 BTIG Research
Neutral19 Aug '16 BTIG
Neutral05 Aug '16 JP Morgan
Overweight26 May '16 Baird
Neutral27 Oct '15 Oppenheimer
Outperform13 May '15 Guggenheim
BuyScreeners with MACK included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Merrimack Pharmaceuticals?
- What is the ticker symbol for Merrimack Pharmaceuticals?
- Does Merrimack Pharmaceuticals pay dividends?
- What sector is Merrimack Pharmaceuticals in?
- What industry is Merrimack Pharmaceuticals in?
- What country is Merrimack Pharmaceuticals based in?
- When did Merrimack Pharmaceuticals go public?
- Is Merrimack Pharmaceuticals in the S&P 500?
- Is Merrimack Pharmaceuticals in the NASDAQ 100?
- Is Merrimack Pharmaceuticals in the Dow Jones?
- When was Merrimack Pharmaceuticals's last earnings report?
- When does Merrimack Pharmaceuticals report earnings?
- Should I buy Merrimack Pharmaceuticals stock now?
What is the primary business of Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
What is the ticker symbol for Merrimack Pharmaceuticals?
The ticker symbol for Merrimack Pharmaceuticals is NASDAQ:MACK
Does Merrimack Pharmaceuticals pay dividends?
No, Merrimack Pharmaceuticals does not pay dividends
What sector is Merrimack Pharmaceuticals in?
Merrimack Pharmaceuticals is in the Healthcare sector
What industry is Merrimack Pharmaceuticals in?
Merrimack Pharmaceuticals is in the Biotechnology industry
What country is Merrimack Pharmaceuticals based in?
Merrimack Pharmaceuticals is headquartered in United States
When did Merrimack Pharmaceuticals go public?
Merrimack Pharmaceuticals's initial public offering (IPO) was on 29 March 2012
Is Merrimack Pharmaceuticals in the S&P 500?
No, Merrimack Pharmaceuticals is not included in the S&P 500 index
Is Merrimack Pharmaceuticals in the NASDAQ 100?
No, Merrimack Pharmaceuticals is not included in the NASDAQ 100 index
Is Merrimack Pharmaceuticals in the Dow Jones?
No, Merrimack Pharmaceuticals is not included in the Dow Jones index
When was Merrimack Pharmaceuticals's last earnings report?
Merrimack Pharmaceuticals's most recent earnings report was on 2 August 2024
When does Merrimack Pharmaceuticals report earnings?
The date for Merrimack Pharmaceuticals's next earnings report has not been announced yet
Should I buy Merrimack Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions